Zimmer Biomet Q3'26 Earnings Preview: EPS Estimate 1.88
Zimmer Biomet is scheduled to report Q3'26 results on November 04 before the market opens. Revenue is estimated at 2.04 billion USD, with EPS expected at 1.88 USD.
Related stories
Nasdaq single-stock trading halt continues, symbol not given — reason not given (10:35 AM ET)
Nasdaq kept trading halted in a single listed security (reason not given) at 10:35 AM ET.
M impact | EQUITY | Nov 03, 2026, 03:50 PM UTC
Apple CEO Says Timing of iPhone Supply-Demand Balance Is Uncertain
Apple’s CEO said the company cannot predict when iPhone supply and demand will balance.
M impact | EQUITY | Nov 03, 2026, 03:34 PM UTC
Argentina’s Metalfor Seeks Preventive Insolvency Proceedings
The agricultural machinery manufacturer sought preventive insolvency proceedings after months of financial crisis and layoffs.
M impact | EQUITY | Nov 03, 2026, 03:34 PM UTC
LUX Infusion Acquires Be Well Memory’s Specialty Infusion Business
LUX Infusion says the acquisition expands access to clinician-led specialty infusion care in Nebraska.
M impact | EQUITY | Nov 03, 2026, 03:34 PM UTC
Embraer Shares Rise More Than 4% After Greece KC-390 Order
Embraer shares rose more than 4% after Greece placed an order for KC-390 aircraft.
M impact | EQUITY | Nov 03, 2026, 03:34 PM UTC
Minda Corporation Q2 Revenue Rises 42.6% to Rs 2,189 Crore
Consolidated operating revenue increased year on year from Rs 1,535 crore in the corresponding period last year. EV products accounted for 35% of new orders.
M impact | EQUITY | Nov 03, 2026, 03:33 PM UTC